Keyphrases
Additional Dose
14%
Adjunctive Therapy
14%
Antiparkinsonian Drugs
14%
B-cell Lymphoma 2 (Bcl-2)
14%
Cardioprotection
100%
Cleaved caspase-3
14%
Cleaved caspase-9
14%
Cytochrome c Release
14%
Glycogen Synthase Kinase 3 (GSK3)
14%
H9c2 Cells
28%
Hydrogen Peroxide
28%
Induced Damage
14%
Infarct Size
14%
Ischemia
42%
Ischemia Injury
14%
Ischemia-reperfusion Injury
100%
Left Anterior Descending Artery
14%
Mitochondrial Cytochrome c
14%
Mitochondrial Integrity
14%
Mitochondrial Membrane Potential
14%
Mitochondrial Swelling
14%
Myocardial Infarction
28%
Myocardial Injury
28%
Neonatal Rat Cardiomyocytes
28%
Nine-level
14%
Occlusion
14%
Oxidative Stress
14%
Phosphorylation
14%
Possible Mechanisms
14%
Protein Kinase
14%
Rasagiline
14%
Rat Model
100%
Reperfusion
71%
Reperfusion Damage
14%
S-enantiomer
14%
Serum-free
14%
Stress-induced
14%
Swelling Capacity
14%
Three-level
14%
TVP1022
100%
Two-level
14%
Ventricular Function
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antiparkinson Agent
12%
Caspase 3
12%
Caspase 9
12%
Cytochrome C
12%
Deterioration
12%
Glycogen Synthase Kinase 3
12%
Heart Infarction
25%
Heart Muscle Injury
25%
Infarction
12%
Ischemia
100%
Protein Kinase C
12%
Rasagiline
100%
Rat Model
100%
Reperfusion Injury
12%